CBOE · HELX
Franklin Genomic Advancements ETF
$45.25-$0.76 (-1.65%)
Franklin Genomic Advancements ETF’s quoted price sits in the upper half of its reported 52-week range, 2.1% below the high.
Loading market information…
AMEX · RMCA · USD
Stock price, dividends
Quote as of Oct 30, 2026, 07:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Rockefeller California Municipal Bond ETF’s quoted price sits in the lower half of its reported 52-week range, 5.28% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Rockefeller California Municipal Bond ETF’s forward annual dividend is $1.10 per share, paid monthly. The forward yield is 4.74% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The Rockefeller California Municipal Bond ETF (RMCA) is an actively managed exchange-traded fund whose primary objective is to generate income exempt from both U.S. federal and California state income taxes. It achieves this by focusing its investments on municipal bonds issued within California. Typically, at least 80% of the fund's net assets, including any capital borrowed for investment purposes, will be allocated to debt securities. The interest income from these bonds is considered free from regular U.S. federal and California state income taxation, based on the bond counsel's opinion at the time of issuance and current tax legislation. Importantly, this fund operates with a non-diversified portfolio.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 09:00 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$45.25-$0.76 (-1.65%)
Franklin Genomic Advancements ETF’s quoted price sits in the upper half of its reported 52-week range, 2.1% below the high.
$36.55-$0.15 (-0.41%)
DoubleLine Fortune 500 Equal Weight ETF’s quoted price sits in the upper half of its reported 52-week range, 7.97% below the high.
$38.71-$0.84 (-2.11%)
Overlay Shares Small Cap Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 10.05% below the high.
$49.82+$0.20 (+0.4%)
Goldman Sachs Dynamic California Municipal Income ETF’s quoted price sits in the lower half of its reported 52-week range, 4.36% below the high.
$21.53-$0.28 (-1.26%)
Adaptive Tactical Rotation ETF’s quoted price sits in the upper half of its reported 52-week range, 8.21% below the high.
$42.27-$0.61 (-1.43%)
Innovator U.S. Equity Accelerated Plus ETF - July’s quoted price sits in the upper half of its reported 52-week range, 2.04% below the high.
$48.29+$0.37 (+0.76%)
First Trust Bloomberg Shareholder Yield ETF’s quoted price sits in the upper half of its reported 52-week range, 0.43% below the high.
$26.24+$0.08 (+0.29%)
Goose Hollow Multi-Strategy Income ETF’s quoted price sits in the upper half of its reported 52-week range, 2.2% below the high.
